Paragon Biosciences is among the life science industry’s most successful company creators, investing billions with its partners to build companies that focus on cell and gene therapy, biology engineering, and advanced biotech businesses.
Jeff and his team at Paragon Biosciences have earned five full FDA approvals in neurology, an accomplishment of which he is especially proud. He is known for innovating, developing and commercializing scientific discoveries in areas of high need.
Throughout his career, Jeff has been recognized with numerous awards and honors, including Entrepreneur of the Year-Pharmaceuticals by the American Business Awards®, a Gold Stevie Award and a Titan Award for biology-based innovation. He serves on the board of Discover Financial Services, the Aspen Institute and the Weizmann Institute.